about
Atrial Fibrillation: The Science behind Its DefianceWithaferin-A reduces type I collagen expression in vitro and inhibits development of myocardial fibrosis in vivoHeart failure with normal ejection fraction: a growing pandemic.Association between depressive symptoms and fibrosis markers: the Cardiovascular Health Study.Evidence for calreticulin attenuation of cardiac hypertrophy induced by pressure overload and soluble agonists.Pan-histone deacetylase inhibitors regulate signaling pathways involved in proliferative and pro-inflammatory mechanisms in H9c2 cellsEffects of tanshinone IIA on the transforming growth factor β1/Smad signaling pathway in rat cardiac fibroblastsFibrosis, not cell size, delineates beta-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo.Cardiac NO signalling in the metabolic syndrome.Cardiac microinjury measured by troponin T predicts collagen metabolism in adults aged >=65 years with heart failure.Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapyReal role of β-blockers in regression of left ventricular mass in hypertension patients: Bayesian network meta-analysis.Nocturnal nondipping and left ventricular hypertrophy in hypertension: an updated review.Left atrial enlargement and right ventricular hypertrophy in essential hypertension.Essential Role of Smooth Muscle STIM1 in Hypertension and Cardiovascular Dysfunction.Which oracle to use for tracking a desynchronized heart? A matter of predictability in contemporary medicine.Left ventricular diastolic dysfunction in newly diagnosed untreated hypertensive patients.The interplay between renin-angiotensin system activation, abnormal myocardial deformation and neurohumoral activation in hypertensive heart disease: a speckle tracking echocardiography study.In vivo quantification of myocardial stiffness in hypertensive porcine hearts using MR elastography.2007 ESH‐ESC Guidelines for the management of arterial hypertension
P2860
Q28072139-3A213D06-D039-4575-9262-62EC530C30A2Q28482173-8F489C58-AD0C-4030-B0A9-5ED2A31AD2ADQ30417324-C085C4A6-8134-48A2-8655-76EA09BA3E7EQ33637776-4CE3958B-EF27-49B3-A73C-0366F9BDEFC8Q33703640-4E5D8D2A-FD0B-4862-8A9E-FE33F99C5EDFQ34515132-A0619E2F-AF32-45C7-B1BC-063F0924E9C4Q34684651-64E948C2-C3CD-418D-959C-D027F9369A31Q35110788-F2D06715-9B49-4B85-9D55-9C911C3BDE30Q35204828-911AC4DE-884B-46B1-8BF3-2E4598E0A970Q35777180-DF43DD98-8D68-4397-8EAF-F87D9B50F7ACQ36013124-8810F1CA-CEAC-4C58-9444-675A6A12BEE6Q37696908-7F177119-5000-42AE-A7D3-AFD68666A5C0Q37763197-A6F42D58-40EB-48D5-9E55-A8C5E90B8970Q39402966-A76285BB-48E0-43E8-B231-C372130E87B4Q41440623-5C8CC57E-1842-4A92-B44F-0739938F1E23Q42318484-824622F4-AF4C-45FA-9074-8F1D695ABF20Q47744683-CC94BBA5-AEC8-4F1C-8889-AFA4BC40C656Q48455995-0135494B-5A43-418C-AA72-2526D73F7AC8Q51183824-B642DA08-0EC5-466D-B88E-6022CDC9EC28Q56970799-2BB97374-5D68-4D03-B5F4-4FC32C45CE48
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Hypertensive myocardial fibrosis.
@ast
Hypertensive myocardial fibrosis.
@en
type
label
Hypertensive myocardial fibrosis.
@ast
Hypertensive myocardial fibrosis.
@en
prefLabel
Hypertensive myocardial fibrosis.
@ast
Hypertensive myocardial fibrosis.
@en
P2860
P356
P1476
Hypertensive myocardial fibrosis
@en
P2093
Cesare Cuspidi
P2860
P356
10.1093/NDT/GFI237
P407
P577
2005-11-01T00:00:00Z